Novavax
NVAX
408 hedge funds and large institutions have $8.45B invested in Novavax in 2021 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 135 increasing their positions, 108 reducing their positions, and 82 closing their positions.
26% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 82
25% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 108
10% more capital invested
Capital invested by funds: $7.7B → $8.45B (+$741M)
5% more funds holding
Funds holding: 389 → 408 (+19)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3.92% less ownership
Funds ownership: 57.58% → 53.66% (-3.9%)
12% less call options, than puts
Call options by funds: $1.09B | Put options by funds: $1.23B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$142M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$59.9M |
| 3 |
Jane Street
New York
|
+$51.8M |
| 4 |
State Street
Boston,
Massachusetts
|
+$46.1M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$34.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$177M |
| 2 |
BlackRock
New York
|
-$168M |
| 3 |
Renaissance Technologies
New York
|
-$122M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$81M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$79.3M |
NVAX Hedge Fund Activity: Q2 2021 in Review
408 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2021, worth a combined $8.45B — up 9.6% from $7.7B a quarter earlier.
Buyers outnumbered sellers: 103 funds opened new NVAX positions and 82 closed out — a net gain of 21 holders — while 135 added to existing stakes and 108 trimmed.
The largest buyer was Vanguard Group, adding an estimated $142M. The largest seller was Wellington Management Group, cutting an estimated $177M.
- 408 institutional investors held Novavax (NVAX) as of Q2 2021, up from 389 in Q1 2021.
- Funds reported $8.45B of Novavax stock for Q2 2021, up 9.6% quarter-over-quarter.
- 103 funds opened new Novavax positions in Q2 2021 and 82 closed out, a net change of +21 holders.
- The largest Novavax buyer in Q2 2021 was Vanguard Group, an estimated $142M added.
- The largest Novavax seller in Q2 2021 was Wellington Management Group, an estimated $177M sold.
Based on aggregated 13F filings for Q2 2021.